Advertisement

Advertisement

FBLG Stock Latest News

FibroBiologics doses first patients in CYWC628 trial

The FlyFibroBiologics doses first patients in CYWC628 trial

FibroBiologics presents preclinical data from CYPS317 program

PremiumThe Fly

FibroBiologics presents preclinical data from CYPS317 program

13d ago

FibroBiologics expands fibroblast-based platform to target Hantavirus

PremiumThe Fly

FibroBiologics expands fibroblast-based platform to target Hantavirus

24d ago

FibroBiologics Expands At-The-Market Equity Offering Capacity

PremiumCompany Announcements

FibroBiologics Expands At-The-Market Equity Offering Capacity

29d ago

FibroBiologics Grants Stock Options to Key Executives

PremiumCompany Announcements

FibroBiologics Grants Stock Options to Key Executives

1M ago

FibroBiologics says fibroblast spheroids drive burn healing, reduce scarring

PremiumThe FlyFibroBiologics says fibroblast spheroids drive burn healing, reduce scarring

1M ago

FibroBiologics releases first batch of CYWC628 for Phase 1/2 trial

The Fly

FibroBiologics releases first batch of CYWC628 for Phase 1/2 trial

1M ago

FibroBiologics downgraded to Hold from Buy at Maxim

The Fly

FibroBiologics downgraded to Hold from Buy at Maxim

1M ago

FibroBiologics Warns of ‘Going Concern’ Risk as Losses Mount and Funding Outlook Darkens

PremiumCompany Announcements

FibroBiologics Warns of ‘Going Concern’ Risk as Losses Mount and Funding Outlook Darkens

1M ago

FibroBiologics Launches New At-The-Market Equity Offering

PremiumCompany Announcements

FibroBiologics Launches New At-The-Market Equity Offering

1M ago

FibroBiologics reports Q1 net loss roughly ($5M)

PremiumThe Fly

FibroBiologics reports Q1 net loss roughly ($5M)

1M ago

FibroBiologics Secures Nasdaq Listing Compliance, Under Monitoring

PremiumCompany Announcements

FibroBiologics Secures Nasdaq Listing Compliance, Under Monitoring

2M ago

FibroBiologics announces compliance with all Nasdaq listing requirements

PremiumThe FlyFibroBiologics announces compliance with all Nasdaq listing requirements

2M ago

FibroBiologics Lowers Quorum Requirement in Amended Bylaws

Company Announcements

FibroBiologics Lowers Quorum Requirement in Amended Bylaws

2M ago

FibroBiologics target adjusted to $8 at H.C. Wainwright after reverse split

The Fly

FibroBiologics target adjusted to $8 at H.C. Wainwright after reverse split

2M ago

FibroBiologics Ends Texas Sublease, Consolidates Houston Operations

PremiumCompany Announcements

FibroBiologics Ends Texas Sublease, Consolidates Houston Operations

2M ago

FBLG Earnings this Week: How Will it Perform?

PremiumPre-Earnings

FBLG Earnings this Week: How Will it Perform?

2M ago

FibroBiologics Implements One-for-Twenty Reverse Stock Split

PremiumCompany Announcements

FibroBiologics Implements One-for-Twenty Reverse Stock Split

2M ago

FibroBiologics Announces Public Offering and Warrant Agreements

PremiumCompany Announcements

FibroBiologics Announces Public Offering and Warrant Agreements

2M ago

FibroBiologics prices $3M public offering

PremiumThe FlyFibroBiologics prices $3M public offering

2M ago

FibroBiologics manufactures first batch of CYWC628 drug product for trials

The Fly

FibroBiologics manufactures first batch of CYWC628 drug product for trials

2M ago

Upcoming Stock Splits This Week (March 30 to April 2) – Stay Invested

Market News

Upcoming Stock Splits This Week (March 30 to April 2) – Stay Invested

2M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >